| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |